23. Does the maximum allowable contrast dose (MACD) predict the risk of contrast induced nephropathy (CIN) in patients with chronic kidney disease (CKD)
CIN is associated with high in-hospital mortality. Some studies recommend the utilization of the MACD formula to guide safe contrast dosing, however the evidence supporting use of this measure is limited. Objective: The purpose of this study was to determine if MACD is helpful in predicting the risk...
Main Authors: | Rasha Abdulaziz Al-Harthi, Mounira Alqahtani, Ahmed Alsaileek, Ali M. Alghamdi |
---|---|
Format: | Article |
Language: | English |
Published: |
Saudi Heart Association
2015-10-01
|
Series: | Journal of the Saudi Heart Association |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1016731515002638 |
Similar Items
-
Computerized Tomography Contrast Induced Nephropathy (CIN) among adult inpatients
by: Luciano Passamani Diogo, et al.
Published: (2014-12-01) -
CONTRAST-INDUCED NEPHROPATHY (CIN): A RAPID OVERVIEW FOR RISK ASSESSMENT AND PREVENTION.
by: Daniele Bissacco
Published: (2017-10-01) -
The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM)
by: Yang Jai-Sing, et al.
Published: (2018-03-01) -
Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients
by: Zaher Armaly, et al.
Published: (2019-01-01) -
Assessment and prevention of contrast induced AKI in CKD
Published: (2014-01-01)